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The authors present the case of an 11-year-old boy
with pharyngitis, treated with amoxicillin, that worsened
on day 7, with cough, high fever and refusal to eat.
Lethargy and respiratory distress were noted. Based on
radiographic ﬁndings of bilateral inﬁltrates he was
diagnosed with pneumonia and started on intravenous
ampicillin and erythromycin. Two days later he
complained of right-sided neck pain and a palpable
mass was identiﬁed. An ultrasound showed partial
thrombosis of the right internal jugular vein and a
lung CT scan revealed multiple septic embolic lesions.
Lemierre syndrome was diagnosed, antibiotic treatment
adjusted and anticoagulation started. A neck CT-scan
showed a large parapharyngeal abscess. His clinical
condition improved gradually and after 3 weeks of
intravenous antibiotics he was discharged home on
oral treatment. This case illustrates the importance of
diagnosing Lemierre syndrome in the presence of
pharyngitis with localised neck pain and respiratory
distress, to prevent potentially fatal complications.
BACKGROUND
Lemierre syndrome (LS) is an uncommon disease,
ﬁrst described by Andre Lemierre in 1936, who
reported 20 cases of ‘anaerobic septicaemia’.1 This
syndrome is characterised by an acute oropharyn-
geal infection followed by ipsilateral septic
thrombophlebitis of the internal jugular vein (IJV),
and is frequently complicated by metastatic infec-
tions via septic emboli. LS usually affects healthy
adolescents and young adults, with a slightly higher
incidence in males.2–4 The most common aetio-
logical agent is Fusobacterium necrophorum.3
With the widespread use of antibiotics in the
management of acute oropharyngeal infections, its
incidence has declined substantially, with no identi-
ﬁable reported cases in the 1950s and 1960s.3–7
However, in the last decades, a few cases have been
published, maybe related to an increase in its inci-
dence and clinical recognition or reﬂecting the
common use of antibiotics, particularly macrolides
(without action against F necrophorum), in the
treatment of pharyngeal infections.6 8 An incidence
between 0.6 and 2.3 per million has been reported,
with death rates ranging from 4% to 18%, and
with signiﬁcant morbidity, speciﬁcally in cases with
delayed diagnosis.2–4
We present this case with the purpose of increas-
ing physician’s awareness of this disorder, since a
high degree of clinical suspicion is warranted to
diagnose this syndrome. Accurate and timely
diagnosis and appropriate therapy are crucial to
prevent its elevated morbidity and mortality.
CASE PRESENTATION
A previously healthy 11-year-old boy presented to
his local hospital complaining of pain when swal-
lowing and low fever. Group A streptococcal rapid
antigen test on a throat swab was negative, and he
was discharged home with the diagnosis of viral
pharyngitis. During the following days he was seen
again in hospital, with no changes on examination,
diagnosis or management.
On day 5 of disease he returned with additional
complaints: cough and high fever. Examination
remained unchanged, and despite a negative group A
streptococcal rapid antigen test, a course of oral
amoxicillin was prescribed. There was no improve-
ment and he returned to the emergency room 2 days
later refusing to eat, lethargic and complaining of
pain in his right shoulder. He appeared acutely ill,
with grunting, increased respiratory rate (up to 30/
min) and transcutaneous oxygen saturation consist-
ently >95% in room air. Examination of his throat
revealed mild erythema and swelling of the orophar-
ynx and on auscultation there was reduced air entry
in both lower lung lobes. The chest x-ray showed
bilateral opacities in both of these lobes, more pro-
nounced on the right, with air bronchogram and
diffuse bilateral bronchopneumonia foci without
effusion (ﬁgure 1). Blood tests showed elevated white
blood cell count with neutrophilia (13×109/l) and
C reactive protein of 19.3 mg/dl. Serologies for
Mycoplasma pneumoniae, Chlamydia pneumoniae,
Ebstein-Barr virus and Cytomegalovirus and blood
cultures were performed. A diagnosis of pneumonia
was made and he was started on intravenous ampicil-
lin and erythromycin.
Figure 1 Chest x-ray.
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In spite of initial clinical improvement, 48 h later (day 9 of
disease) he developed respiratory distress, high fever, abdominal
and right-sided neck pain. Examination revealed a small right-
sided cervical mass towards the back of the anterior triangle.
INVESTIGATIONS
An ultrasound showed lymphadenopathies and partial throm-
bosis of the right IJV.
A thoracic CT scan revealed multiple cavitated pneumonic
foci compatible with septic embolic lesions.
TREATMENT
On the basis of these ﬁndings, the diagnosis of Lemierre syn-
drome was made and antibiotics were changed to piperacillin+
tazobactam and metronidazole. Anticoagulation with subcutane-
ous enoxaparin was started.
OUTCOME AND FOLLOW-UP
He was transferred to the joint care of the ear–nose and throat
(ENT) and paediatric infectious diseases teams at a tertiary
centre. On arrival his tonsils looked asymmetrical. A neck CT
scan with contrast was performed and conﬁrmed thrombosis of
the right IJV and also showed a large parapharyngeal loculated
heterogeneous lesion compatible with an abscess, causing dis-
placement of the airway to the left, with extension to the
carotid space and encirclement of the carotid artery without
compression or inﬁltration of the artery wall (ﬁgure 2).
The ENT team elected to pursue an expectant approach due
to the proximity of the abscess to the internal carotid artery. He
required oxygen supplementation during the ﬁrst 24 h and his
general condition improved gradually. Laboratory markers nor-
malised within 1 week. Blood cultures were negative and serolo-
gies did not show acute infection.
He was discharged home after 3 weeks of intravenous antibio-
tics on oral amoxicillin+clavulanic acid and metronidazole, com-
pleting 6 weeks of treatment. Anticoagulation was continued for
6 months.
The patient remained asymptomatic after discharge.
Follow-up ultrasound scans of the jugular vein still showed per-
sistent thrombus with no further extension. A follow-up CT
scan of the chest was normal 6 months later.
DISCUSSION
In paediatrics, the natural course of pharyngitis is typically com-
plete resolution within 1 week. An atypical course of the
disease, with worsening symptoms or these lasting longer than
expected or emergence of painful unilateral swelling of the
neck, should raise other diagnoses, including Lemierre
syndrome.
The progression of clinical symptoms closely follows the
disease course and can be divided into four stages: in the ﬁrst
stage clinical ﬁndings are not speciﬁc and depend on the
primary site of infection (usually the oropharynx). In the second
and third stages there is invasion of the lateral parapharyngeal
space leading to IJV thrombophlebitis, often manifesting as pain
and unilateral swelling at the angle of the jaw and along the
sternocleidomastoid muscle (present in 50% of cases).7 The
fourth and last stage corresponds to metastatic spread, which
depends on the clinical ﬁndings and the site of the septic embol-
ism (most commonly the lung, with abscesses and respiratory
distress).4
The causative organisms are usually part of the normal oro-
pharyngeal ﬂora. The most common pathogen is F necrophorum
(more than 50% of the cases).9 Other pathogens include other
Fusobacterium species (eg, Fusobacterium nucleatum), Eikenella
corrodens, Porphyromonas asaccharolytica, Streptococcus pyo-
genes, Bacteroides and also Staphylococcus aureus, including
methicillin-resistant strains (MRSA).10–12
Early diagnosis and antibiotic therapy are essential for a good
clinical outcome. Intravenous therapy with coverage for anaer-
obic pathogens during 3–6 weeks is recommended, and should
be initiated as soon as possible. Drainage of purulent collections
is highly encouraged, both for rapid recovery and for causative
pathogen identiﬁcation. Unfortunately we were not able to iden-
tify a microorganism. Blood cultures were obtained when the
patient was already on antibiotics and surgical drainage was not
chosen by the ENT team. As a result, metronidazole for
anaerobes and piperacillin+tazobactam for coverage of
Gram-positive bacteria, including S aureus were started. MRSA
are very rarely found in community-acquired infections in our
institution and in the central region of Portugal (unpublished
data) and prevalence of carriage in healthy young children
remains extremely low.13 However, in countries with a high
incidence of community-acquired MRSA, adequate empirical
Figure 2 Neck CT scan with parapharyngeal abscess (A) and thrombosis of right internal jugular vein (B).
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antibiotic treatment should be chosen to provide suitable
coverage.
Other surgeries, such as surgical ligation or excision of the
IJV, although rarely used, are described in the setting of
on-going sepsis or in patients without response to antibiotic
therapy.
The role of anticoagulation remains controversial, and there
are no controlled studies to assess its value in septic thrombo-
phlebitis of the IJV. Some authors recommend its use only if
there is evidence of extension of the thrombus.10 Others advo-
cate it as an adjunct to antibiotic therapy, referring its potential
for faster resolution of thrombophlebitis and bacteraemia, thus
limiting the development of new metastatic foci.4
Learning points
▸ Unusual clinical course of frequent diseases should alert
physicians for complications.
▸ Lemierre syndrome still remains an important cause of
morbidity due to rapid disease progression and potential
diagnostic delays.
▸ Early diagnosis and treatment is important to avoid serious
complications.
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